ANTHONY “NINO” SIRECI, MD, M.SC.
TOMORROW’S BREAKTHROUGHS TODAY SCIENTIFIC SYMPOSIUM SERIES
Blood Tests and Beyond: Redefining Alzheimer’s Care Through Biomarkers
Tuesday, January 26,2027 5:30 PM
Dixon Education Building
Biomarkers are key to helping identify the right patients for the right therapies at the right time while also accelerating the development of new treatments. Dr. Anthony “Nino” Sireci, Senior Vice President of Clinical Biomarkers, Laboratories and Diagnostics at Eli Lilly and Company, will discuss how advances in biomarkers, including blood-based tests, are transforming Alzheimer’s research and care. Drawing on lessons from oncology, he will explore how these innovations are helping pave the way for more targeted treatments and better outcomes for patients, ultimately moving us toward the gold standard of precision medicine for Alzheimer’s disease.
Blood Tests and Beyond: Redefining Alzheimer’s Care Through Biomarkers
Tuesday, January 26,2027 5:30 PM
Dixon Education Building
Biomarkers are key to helping identify the right patients for the right therapies at the right time while also accelerating the development of new treatments. Dr. Anthony “Nino” Sireci, Senior Vice President of Clinical Biomarkers, Laboratories and Diagnostics at Eli Lilly and Company, will discuss how advances in biomarkers, including blood-based tests, are transforming Alzheimer’s research and care. Drawing on lessons from oncology, he will explore how these innovations are helping pave the way for more targeted treatments and better outcomes for patients, ultimately moving us toward the gold standard of precision medicine for Alzheimer’s disease.